[1] 李思霖,常健菲,郭力. 李显筑教授治疗胰岛素抵抗综合征经验[J]. 吉林中医药,2012,3(2):128-130.
[2] Shi HL,Zheng QL,WU DZ. The preventive effect of evodia-mineon vascular hypertrophy in obese rats[J]. Chin Pharmacol Bull,2011,27(12):1687-1692.
[3] Muse ED,Obici S,Bhanot S,et al. Role of resistin in dietinducedhepatic insulin resistance[J]. J Clin Invest,2004,114:232-239.
[4] 中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[S].北京:人民卫生出版社,2006:4.
[5] 王吉耀.内科学[M].北京:人民卫生出版社,2002:1007 -1011.
[6] 李光伟,潘孝仁,Stephen L,等. 检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660.
[7] 危北海,贾葆鹏.单纯性肥胖病的诊断及疗效评定标准[J].中国中西医结合杂志,1998,18(5):317-319.
[8] Robert JJ,Cummins JC,Wolf RR,et al. Quantitative aspects of glucoseproduction and metabolism in health elderly subjects[J]. Diabetes,1982,31(2):203.
[9] Reven GM,Lithell H,Landsberg L. Hypertension and associated metabolic abnormalities the roleof insulin resistance and the symothoadrenal system[J]. New Eng Med,1996,334(5):374-378.
[10] 鲁谨,邹大进,张家庆. 肿瘤坏死因子-α致胰岛素抵抗[J].中国病理生理杂志,1999,15(10):1146-1148.
[11] 陈维铭,王馨然. 半夏白术天麻汤对单纯性肥胖患者胰岛素抵抗的影响[J]. 现代中西医结合杂志,2004,13(2):153-155.